![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: SH3RF3 |
Gene summary for SH3RF3 |
![]() |
Gene information | Species | Human | Gene symbol | SH3RF3 | Gene ID | 344558 |
Gene name | SH3 domain containing ring finger 3 | |
Gene Alias | POSH2 | |
Cytomap | 2q13 | |
Gene Type | protein-coding | GO ID | GO:0000165 | UniProtAcc | Q8TEJ3 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
344558 | SH3RF3 | C43 | Human | Oral cavity | OSCC | 7.87e-03 | -1.68e-01 | 0.1704 |
344558 | SH3RF3 | C46 | Human | Oral cavity | OSCC | 9.50e-03 | -1.68e-01 | 0.1673 |
344558 | SH3RF3 | C08 | Human | Oral cavity | OSCC | 7.87e-03 | -1.63e-01 | 0.1919 |
344558 | SH3RF3 | EOLP-1 | Human | Oral cavity | EOLP | 2.90e-20 | 5.89e-01 | -0.0202 |
344558 | SH3RF3 | EOLP-2 | Human | Oral cavity | EOLP | 1.09e-02 | 2.90e-01 | -0.0203 |
344558 | SH3RF3 | NEOLP-1 | Human | Oral cavity | NEOLP | 1.21e-12 | 5.91e-01 | -0.0194 |
344558 | SH3RF3 | NEOLP-2 | Human | Oral cavity | NEOLP | 4.12e-12 | 4.27e-01 | -0.0196 |
344558 | SH3RF3 | NEOLP-3 | Human | Oral cavity | NEOLP | 5.82e-13 | 4.81e-01 | -0.0191 |
344558 | SH3RF3 | SYSMH1 | Human | Oral cavity | OSCC | 3.94e-04 | -1.61e-01 | 0.1127 |
Page: 1 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Oral Cavity | ![]() | EOLP: Erosive Oral lichen planus |
LP: leukoplakia | ||
NEOLP: Non-erosive oral lichen planus | ||
OSCC: Oral squamous cell carcinoma |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:003109816 | Oral cavity | OSCC | stress-activated protein kinase signaling cascade | 141/7305 | 247/18723 | 5.74e-09 | 1.25e-07 | 141 |
GO:005140316 | Oral cavity | OSCC | stress-activated MAPK cascade | 134/7305 | 239/18723 | 6.02e-08 | 1.09e-06 | 134 |
GO:007030210 | Oral cavity | OSCC | regulation of stress-activated protein kinase signaling cascade | 111/7305 | 195/18723 | 2.82e-07 | 4.34e-06 | 111 |
GO:003287210 | Oral cavity | OSCC | regulation of stress-activated MAPK cascade | 108/7305 | 192/18723 | 8.97e-07 | 1.22e-05 | 108 |
GO:00072548 | Oral cavity | OSCC | JNK cascade | 90/7305 | 167/18723 | 6.49e-05 | 5.26e-04 | 90 |
GO:00463288 | Oral cavity | OSCC | regulation of JNK cascade | 74/7305 | 133/18723 | 7.22e-05 | 5.69e-04 | 74 |
GO:00703045 | Oral cavity | OSCC | positive regulation of stress-activated protein kinase signaling cascade | 66/7305 | 128/18723 | 2.58e-03 | 1.13e-02 | 66 |
GO:00518657 | Oral cavity | OSCC | protein autoubiquitination | 40/7305 | 73/18723 | 4.45e-03 | 1.79e-02 | 40 |
GO:00328744 | Oral cavity | OSCC | positive regulation of stress-activated MAPK cascade | 64/7305 | 126/18723 | 4.67e-03 | 1.87e-02 | 64 |
GO:00434107 | Oral cavity | OSCC | positive regulation of MAPK cascade | 213/7305 | 480/18723 | 8.71e-03 | 3.16e-02 | 213 |
GO:00463301 | Oral cavity | OSCC | positive regulation of JNK cascade | 46/7305 | 89/18723 | 1.01e-02 | 3.50e-02 | 46 |
GO:003109824 | Oral cavity | EOLP | stress-activated protein kinase signaling cascade | 49/2218 | 247/18723 | 1.89e-04 | 1.94e-03 | 49 |
GO:005140324 | Oral cavity | EOLP | stress-activated MAPK cascade | 47/2218 | 239/18723 | 3.11e-04 | 2.91e-03 | 47 |
GO:007030224 | Oral cavity | EOLP | regulation of stress-activated protein kinase signaling cascade | 39/2218 | 195/18723 | 6.89e-04 | 5.70e-03 | 39 |
GO:003287224 | Oral cavity | EOLP | regulation of stress-activated MAPK cascade | 37/2218 | 192/18723 | 1.87e-03 | 1.21e-02 | 37 |
GO:004632814 | Oral cavity | EOLP | regulation of JNK cascade | 27/2218 | 133/18723 | 3.44e-03 | 1.98e-02 | 27 |
GO:005186521 | Oral cavity | EOLP | protein autoubiquitination | 17/2218 | 73/18723 | 4.43e-03 | 2.41e-02 | 17 |
GO:000725416 | Oral cavity | EOLP | JNK cascade | 31/2218 | 167/18723 | 7.30e-03 | 3.54e-02 | 31 |
GO:005140332 | Oral cavity | NEOLP | stress-activated MAPK cascade | 45/2005 | 239/18723 | 1.18e-04 | 1.41e-03 | 45 |
GO:003109832 | Oral cavity | NEOLP | stress-activated protein kinase signaling cascade | 46/2005 | 247/18723 | 1.30e-04 | 1.52e-03 | 46 |
Page: 1 2 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
SH3RF3 | SNV | Missense_Mutation | c.1166N>G | p.His389Arg | p.H389R | Q8TEJ3 | protein_coding | deleterious(0.04) | benign(0.443) | TCGA-HU-A4G8-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Chemotherapy | 5-fluorouracil | SD | |
SH3RF3 | SNV | Missense_Mutation | novel | c.1706N>A | p.Ala569Asp | p.A569D | Q8TEJ3 | protein_coding | tolerated(0.07) | benign(0.317) | TCGA-VQ-A94U-01 | Stomach | stomach adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |